BioWorld

March 6, 2008

No Buyers, So PDL Plans a Smaller, Leaner Future

After failing to attract a buyer, PDL BioPharma Inc. said it ended efforts to actively sell the company or its key assets, and took steps to streamline operations. (BioWorld Today) Read More

Bevirimat Phase IIb Data Help Panacos Locate Responders

PanGenetics Raises $34M For Antibody Pipeline

Ception Launches Phase II/III for Pediatric Esophagus Disorder

Other News To Note

Clinic Roundup

Today's news in brief

BioWorld

BioWorld briefs for Dec. 10, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 10, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

US lawmakers demand that Kennedy be held accountable

BioWorld

As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...

Illustration of head with maze that is missing parts

CTAD 2025: The challenges of combination therapies for dementia

BioWorld Science

At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...